Literature DB >> 12695508

Oligolysine-based oligosaccharide clusters: selective recognition and endocytosis by the mannose receptor and dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin.

Natacha Frison1, Maureen E Taylor, Elizabeth Soilleux, Marie-Thérèse Bousser, Roger Mayer, Michel Monsigny, Kurt Drickamer, Annie-Claude Roche.   

Abstract

Dendritic cells are potent antigen-presenting cells that express several membrane lectins, including the mannose receptor and DC-SIGN (dendritic cell-specific ICAM-3-grabbing nonintegrin). To identify highly specific ligands for these dendritic cell receptors, oligosaccharides were converted into glycosynthons (Os1) and were used to prepare oligolysine-based glycoclusters, Os-[Lys(Os)]n-Ala-Cys-NH2. Clusters containing two to six dimannosides as well as clusters containing four or five pentasaccharides (Lewisa or Lewisx) or hexasaccharides (Lewisb) were synthesized. The thiol group of the appended cysteine residue allows easy tagging by a fluorescent probe or convenient substitution with an antigen. Surface plasmon resonance was used to determine the affinity of the different glycoclusters for purified mannose receptor and DC-SIGN, whereas flow cytometry and confocal microscopy analysis allowed assessment of cell uptake of fluoresceinyl-labeled glycoclusters. Dimannoside clusters are recognized by the mannose receptor with an affinity constant close to 106 liter.mol-1 but have a very low affinity for DC-SIGN (less than 104 liter x mol-1). Conversely, Lewis clusters have a higher affinity toward DC-SIGN than toward the mannose receptor. Dimannoside clusters are efficiently taken up by human dendritic cells as well as by rat fibroblasts expressing the mannose receptor but not by HeLa cells or rat fibroblasts expressing DC-SIGN; DC-SIGN-expressing cells take up Lewis clusters. The results suggest that ligands containing dimannoside clusters can be used specifically to target the mannose receptor, whereas ligands containing Lewis clusters will be targeted to DC-SIGN.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695508     DOI: 10.1074/jbc.M302483200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Non-carbohydrate inhibitors of the lectin DC-SIGN.

Authors:  M Jack Borrok; Laura L Kiessling
Journal:  J Am Chem Soc       Date:  2007-09-29       Impact factor: 15.419

2.  Preferences for uptake of carbohydrate-coated liposomes by C-type lectin receptors as antigen-uptake receptors.

Authors:  Yoko Kawauchi; Yasuhiro Kuroda; Naoya Kojima
Journal:  Glycoconj J       Date:  2012-06-26       Impact factor: 2.916

Review 3.  Design and creativity in synthesis of multivalent neoglycoconjugates.

Authors:  Yoann M Chabre; René Roy
Journal:  Adv Carbohydr Chem Biochem       Date:  2010       Impact factor: 12.200

4.  Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor.

Authors:  Greg A Snyder; Jennifer Ford; Parizad Torabi-Parizi; James A Arthos; Peter Schuck; Marco Colonna; Peter D Sun
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Lewis X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune response.

Authors:  Jingxue Wang; Yongmin Zhang; Jing Wei; Xiaoping Zhang; Bei Zhang; Zhenyuan Zhu; Wei Zou; Yiqin Wang; Zhirong Mou; Bin Ni; Yuzhang Wu
Journal:  Immunology       Date:  2007-03-20       Impact factor: 7.397

6.  DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells.

Authors:  Kinga K Hosszu; Alisa Valentino; Uma Vinayagasundaram; Rama Vinayagasundaram; M Gordon Joyce; Yan Ji; Ellinor I B Peerschke; Berhane Ghebrehiwet
Journal:  Blood       Date:  2012-06-13       Impact factor: 22.113

7.  Laminin and fibronectin treatment leads to generation of dendritic cells with superior endocytic capacity.

Authors:  Samuel García-Nieto; Ramneek K Johal; Kevin M Shakesheff; Mohamed Emara; Pierre-Joseph Royer; David Y S Chau; Farouk Shakib; Amir M Ghaemmaghami
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

8.  AM3 modulates dendritic cell pathogen recognition capabilities by targeting DC-SIGN.

Authors:  Diego Serrano-Gómez; Rocío T Martínez-Nuñez; Elena Sierra-Filardi; Nuria Izquierdo; María Colmenares; Jesús Pla; Luis Rivas; Javier Martinez-Picado; Jesús Jimenez-Barbero; José Luis Alonso-Lebrero; Salvador González; Angel L Corbí
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

9.  Multivalent Cluster Nanomolecules for Inhibiting Protein-Protein Interactions.

Authors:  Elaine A Qian; Yanxiao Han; Marco S Messina; Heather D Maynard; Petr Král; Alexander M Spokoyny
Journal:  Bioconjug Chem       Date:  2019-09-23       Impact factor: 4.774

10.  Mutation in the DC-SIGN cytoplasmic triacidic cluster motif markedly attenuates receptor activity for phagocytosis and endocytosis of mannose-containing ligands by human myeloid cells.

Authors:  Abul K Azad; Jordi B Torrelles; Larry S Schlesinger
Journal:  J Leukoc Biol       Date:  2008-09-04       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.